Full text is available at the source.
Abstract
Optimal timing for initiating liraglutide in patients with persistent obesity may be determined six months after metabolic and bariatric surgery.
- Persistent obesity is defined as a BMI of 28 kg/m² or greater.
- The study focuses on patients in China who have undergone metabolic and bariatric surgery.
- Understanding the timing for liraglutide initiation could address gaps in postoperative weight management.
- The findings may help inform treatment strategies for maintaining weight loss after surgery.
Simplified